124 related articles for article (PubMed ID: 35105169)
1. Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patients.
Nwankwo C; Shah R; Shah A; Corman S; Kebede N
Future Oncol; 2022 Mar; 18(8):965-977. PubMed ID: 35105169
[No Abstract] [Full Text] [Related]
2. Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapy.
Kebede N; Shah R; Shah A; Corman S; Nwankwo C
Future Oncol; 2022 Mar; 18(8):953-964. PubMed ID: 35094566
[No Abstract] [Full Text] [Related]
3. Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma.
Aly A; Johnson C; Yang S; Botteman MF; Rao S; Hussain A
J Med Econ; 2019 Jul; 22(7):662-670. PubMed ID: 30836812
[No Abstract] [Full Text] [Related]
4. Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population.
Shah R; Corman S; Shah A; Kebede N; Nwankwo C
J Med Econ; 2021; 24(1):1221-1230. PubMed ID: 34686073
[TBL] [Abstract][Full Text] [Related]
5. Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USA.
Healey MJ; Seal B; Princic N; Black D; Malangone-Monaco E; Azad NS; Smoot RL
Adv Ther; 2022 Dec; 39(12):5530-5545. PubMed ID: 36241962
[TBL] [Abstract][Full Text] [Related]
6. Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States.
Kearney M; Thokagevistk K; Boutmy E; Bharmal M
J Med Econ; 2018 Dec; 21(12):1159-1171. PubMed ID: 30149739
[TBL] [Abstract][Full Text] [Related]
7. Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
Tangjitgamol S; Anderson BO; See HT; Lertbutsayanukul C; Sirisabya N; Manchana T; Ilancheran A; Lee KM; Lim SE; Chia YN; Domingo E; Kim YT; Lai CH; Dali AZ; Supakapongkul W; Wilailak S; Tay EH; Kavanagh J;
Lancet Oncol; 2009 Nov; 10(11):1119-27. PubMed ID: 19880066
[TBL] [Abstract][Full Text] [Related]
8. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
[TBL] [Abstract][Full Text] [Related]
9. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
Ren J; Asche CV; Shou Y; Galaznik A
J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
[TBL] [Abstract][Full Text] [Related]
10. Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.
Dispenzieri A; Zonder J; Hoffman J; Wong SW; Liedtke M; Abonour R; D'Souza A; Lee C; Cote S; Potluri R; Ammann E; Tran N; Lam A; Nair S
Amyloid; 2023 Jun; 30(2):161-168. PubMed ID: 36282014
[TBL] [Abstract][Full Text] [Related]
11. Cost of care for the initial management of cervical cancer in women with commercial insurance.
Blanco M; Chen L; Melamed A; Tergas AI; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2021 Mar; 224(3):286.e1-286.e11. PubMed ID: 32818476
[TBL] [Abstract][Full Text] [Related]
12. Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.
Ray S; Bonthapally V; McMorrow D; Bonafede M; Landsman-Blumberg P
J Comp Eff Res; 2013 Mar; 2(2):195-206. PubMed ID: 24236561
[TBL] [Abstract][Full Text] [Related]
13. The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis.
Katanyoo K; Riewpaiboon A; Chaikledkaew U; Thavorncharoensap M
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3171-3179. PubMed ID: 34710993
[TBL] [Abstract][Full Text] [Related]
14. Management of endometrial carcinoma with cervical involvement. An unsettled issue.
Menczer J
Eur J Gynaecol Oncol; 2005; 26(3):245-55. PubMed ID: 15991521
[TBL] [Abstract][Full Text] [Related]
15. Informing health policy in Japan: A mixed-model estimation to compare the cost of illness of cervical cancer and endometrial cancer.
Hayata E; Seto K; Kitazawa T; Matsumoto K; Morita M; Hasegawa T
J Obstet Gynaecol Res; 2016 Apr; 42(4):446-56. PubMed ID: 26712320
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns and direct medical costs among patients with advanced hepatocellular carcinoma.
Aly A; Malangone-Monaco E; Noxon V; Henriques C; Benavente F; Kim A
Curr Med Res Opin; 2020 Nov; 36(11):1813-1823. PubMed ID: 32969741
[TBL] [Abstract][Full Text] [Related]
17. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
[TBL] [Abstract][Full Text] [Related]
18. Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer.
Desille-Gbaguidi H; Hebert T; Paternotte-Villemagne J; Gaborit C; Rush E; Body G
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):348-52. PubMed ID: 24135382
[TBL] [Abstract][Full Text] [Related]
19. Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
Viswanathan AN; Buttin BM; Kennedy AM
Radiographics; 2008; 28(1):289-307. PubMed ID: 18444279
[No Abstract] [Full Text] [Related]
20. Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma.
Yasenchak CA; Tseng WY; Yap M; Rembert D; Patt DA
Leuk Lymphoma; 2015; 56(11):3143-9. PubMed ID: 25860233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]